<http://webisa.webdatacommons.org/prov/185392422>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/233446247> .
<http://webisa.webdatacommons.org/prov/21736513>	<http://www.w3.org/ns/prov#wasDerivedFrom>	<http://webisa.webdatacommons.org/233446247> .
<http://webisa.webdatacommons.org/233446247>	<http://www.w3.org/1999/02/22-rdf-syntax-ns#type>	<http://www.w3.org/ns/prov#Entity> .
<http://webisa.webdatacommons.org/233446247>	<http://www.w3.org/ns/prov#wasQuotedFrom>	<google.com> .
<http://webisa.webdatacommons.org/233446247>	<http://www.w3.org/ns/prov#value>	"The mono-acylated insulin analogs of the present invention are suitable for treating conditions such as diabetes or hyperglycemia." .